Activation of
-Catenin-Tcf Signaling in Colon Cancer by Mutations in
-Catenin or APC
Patrice J. Morin,
*
Andrew B. Sparks,
*
Vladimir Korinek,
Nick Barker,
Hans Clevers,
Bert Vogelstein,
Kenneth W. Kinzler
Inactivation of the adenomatous polyposis coli (APC)
tumor suppressor gene initiates colorectal neoplasia. One of the
biochemical activities associated with the APC protein is
down-regulation of transcriptional activation mediated by
-catenin
and T cell transcription factor 4 (Tcf-4). The protein products
of mutant APC genes present in colorectal tumors were found
to be defective in this activity. Furthermore, colorectal tumors with
intact APC genes were found to contain activating mutations
of
-catenin that altered functionally significant
phosphorylation sites. These results indicate that
regulation of
-catenin is critical to APC's tumor suppressive
effect and that this regulation can be circumvented by mutations in
either APC or
-catenin.
P. J. Morin and B. Vogelstein, Howard Hughes Medical Institute and
Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD
21231, USA.
A. B. Sparks and K. W. Kinzler, Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA.
V. Korinek, N. Barker, H. Clevers, Department of Immunology, University
Hospital, 35008 GA, Utrecht, The Netherlands.
*
These authors contributed equally to this work.
To whom correspondence should be addressed.